Ueda Takashi, Takeyama Yoshifumi, Yasuda Takeo, Matsumura Naoki, Sawa Hidehiro, Nakajima Takahiro, Kuroda Yoshikazu
Department of Gastroenterological Surgery, Kobe University Graduate School of Medical Sciences, Kobe, Japan.
J Surg Res. 2006 Aug;134(2):223-30. doi: 10.1016/j.jss.2005.12.032. Epub 2006 Feb 20.
We have demonstrated that apoptosis was detected in liver and kidney cells in severe acute pancreatitis and that cellular injury because of apoptosis may be involved in the mechanism of multiple organ dysfunction syndrome. Vascular endothelial growth factor (VEGF) is a glycoprotein with potent angiogenic, mitogenic, and vascular permeability-enhancing activities specific for endothelial cells. It has been reported that VEGF is implicated in many diseases such as cancer and inflammation.
Serum VEGF concentrations were determined in patients with acute pancreatitis at the time of admission, and the relationships with severity, blood biochemical parameters on admission, organ dysfunction during the clinical course, and prognosis were analyzed. Moreover, to clarify the role of VEGF in acute pancreatitis, effects of VEGF were investigated in experimental severe acute pancreatitis.
Serum VEGF levels were significantly elevated in patients with acute pancreatitis. Serum VEGF levels were not related to severity or prognosis. In male patients, among the various blood biochemical parameters, serum lactate dehydrogenase, and blood urea nitrogen levels were positively correlated with serum VEGF levels. Serum VEGF levels with organ dysfunction (liver and kidney) were higher than those without organ dysfunction. In rat experimental severe acute pancreatitis, serum VEGF levels were significantly elevated. Recombinant VEGF did not affect the lung water content, volume of ascitic fluid, hematocrit, or serum amylase, but improved the hepatic and renal dysfunctions. Apoptosis of liver and kidney was significantly inhibited by the administration of VEGF.
These results suggest that VEGF is closely related to organ dysfunction in severe acute pancreatitis, and that VEGF may function as not a vascular permeability factor, but a protective factor via the anti-apoptotic effect against the organ injuries in this disease.
我们已经证明,在重症急性胰腺炎患者的肝和肾细胞中可检测到细胞凋亡,且凋亡所致的细胞损伤可能参与了多器官功能障碍综合征的发病机制。血管内皮生长因子(VEGF)是一种糖蛋白,对内皮细胞具有强大的血管生成、促有丝分裂和增强血管通透性的活性。据报道,VEGF与许多疾病如癌症和炎症有关。
测定急性胰腺炎患者入院时血清VEGF浓度,并分析其与疾病严重程度、入院时血液生化参数、临床过程中的器官功能障碍及预后的关系。此外,为阐明VEGF在急性胰腺炎中的作用,在实验性重症急性胰腺炎中研究了VEGF的作用。
急性胰腺炎患者血清VEGF水平显著升高。血清VEGF水平与疾病严重程度或预后无关。在男性患者中,在各种血液生化参数中,血清乳酸脱氢酶和血尿素氮水平与血清VEGF水平呈正相关。发生器官功能障碍(肝和肾)患者的血清VEGF水平高于未发生器官功能障碍者。在大鼠实验性重症急性胰腺炎中,血清VEGF水平显著升高。重组VEGF不影响肺含水量、腹水体积、血细胞比容或血清淀粉酶,但改善了肝和肾功能障碍。给予VEGF可显著抑制肝和肾的细胞凋亡。
这些结果表明,VEGF与重症急性胰腺炎中的器官功能障碍密切相关,并且VEGF在该疾病中可能并非作为血管通透性因子发挥作用,而是通过对器官损伤的抗凋亡作用起到保护因子的作用。